TITLE

CRYPTOME GETS OPTION FOR ANTI-INFLAMMATORY DRUG LICENSE

PUB. DATE
April 2005
SOURCE
Worldwide Biotech;Apr2005, Vol. 17 Issue 4, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on the agreement between pharmaceutical firm Cryptome Pharmaceuticals Ltd. and the University of Virginia for the exclusive licensing rights to a novel class of protein-derived anti-inflammatory drug. Terms of the agreement; Characteristics of the drug; Information on the operations of Cryptome Pharmaceuticals Ltd.
ACCESSION #
16580999

 

Related Articles

  • Evotec Taps Chinese Market Via Conba Deal for EVT 401. Moran, Nuala // BioWorld Today;5/3/2012, Vol. 23 Issue 86, p1 

    The article reports on the out-licensing deal of Evotec AG with Hangzhou, China-based Conba Pharmaceutical Co. Ltd. for its P2X7 antagonist EVT 402. The compound can be used in treating inflammatory diseases, including rheumatoid arthritis. The deal allows Evotec to earn double-digit royalties...

  • Controlled inflammation. Bureau, Stéphanie // Alive: Canada's Natural Health & Wellness Magazine;Oct2008, Issue 312, p114 

    The article offers information on the importance of controlling inflamamation of the body in Canada. It mentions that the term is a purposeful physiological process of the body prior to healing, but one should be careful in choosing the right anti-inflammatories in the market because of its...

  • Sample Pretreatment and Determination of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) in Pharmaceutical Formulations and Biological Samples (Blood, Plasma, Erythrocytes) by HPLC-UV-MS and �-HPLC. Sultan, Mohamed; Stecher, G�nther; St�ggl, Wolfgang M.; Bakry, Rania; Zaborski, P.; Huck, C. W.; El Kousy, Nagla M.; Bonn, G�nther K. // Current Medicinal Chemistry;2005, Vol. 12 Issue 5, p573 

    The article discusses the qualitative and quantitative determination of non-steroidal antiinflammatory drugs like salicin, salicylic acid, tenoxicam, ketorolac, piroxicam, tolmetin, naproxen, flurbiprofen, diclofenac and ibuprofen by reversed phase high performance liquid chromatography...

  • Daheim statt im Pflegeheim. Gyr, Stefan // Baublatt;7/10/2015, Issue 28, p12 

    No abstract available.

  • Non-steroidal Anti-inflammatory Drugs Ranking by Nondeterministic Assessments of Probabilistic Type. MOLDOVEANU, Luiza Mădălina; ŢIGAN, Ştefan; CADARIU, Andrei ACHIMAŞ // Applied Medical Informatics;Sep2012, Vol. 31 Issue 3, p37 

    With a number of common therapeutic prescriptions, common mechanisms, common pharmacological effects - analgesic, antipyretic and anti-inflammatory (acetaminophen excepted), common side effects (SE) (platelet dysfunction, gastritis and peptic ulcers, renal insufficiency in susceptible patients,...

  • Anti-Inflammatory (Nonsteroidal) Drugs. Simeonova, Petia P.; Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p24 

    This article offers information about several anti-inflammatory or nonsteroidal drugs (NSAID). These drugs belong to a group of dissimilar agents which are used to treat various conditions. It has analgesic, anti-inflammatory and antipyretic properties. The characteristics of NSAID drugs are...

  • New risk found for NSAIDs.  // Cortlandt Forum;9/25/2005, Vol. 18 Issue 9, p18 

    Cites a study which found that older men who take nonsteroidal anti-inflammatory drugs are twice as likely to develop urinary retention as nonusers. Coordination of the controls by age and calendar time; Use of aspirin; Capability of the drugs to inhibit prostaglandin synthesis.

  • anti-inflammatory (Major drug group).  // Royal Society of Medicine: Medicines;2002, p73 

    The article presents information on anti-inflammatory drugs. These agents are used to reduce inflammation. The non-steroidal anti-inflammatory drugs, such as aspirin and ibuprofen, can give effective relief from inflammatory pain, tissue swelling, joint immobilization and can also lower raised...

  • Short-term NSAIDs use does not raise MI risk.  // GP: General Practitioner;12/2/2005, p5 

    The article reports that the short-term use of traditional nonsteroidal anti-inflammatory agents does not increase the risk of myocardial infarction (MI). The latest research is a case-control study that included 4,975 patients with acute MI aged 50 to 84 years from Great Britain General...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics